UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 40.492

Sortiert nach

A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis

Proceedings of the National Academy of Sciences - PNAS, 2023-01, Vol.120 (2), p.e2211977120-e2211977120

2023

Link zum Volltext

Verfügbarkeit prüfen

Ions and blockers in potassium channels: insights from free energy simulations

Biochimica et biophysica acta, 2005-02, Vol.1747 (1), p.109-120

2005

Link zum Volltext

Verfügbarkeit prüfen

3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel

Bioorganic & medicinal chemistry, 2019-04, Vol.27 (7), p.1292-1307

2019

Link zum Volltext

Verfügbarkeit prüfen

K Ca channel blockers increase effectiveness of the EGF receptor TK inhibitor erlotinib in non-small cell lung cancer cells (A549)

Scientific reports, 2021-09, Vol.11 (1), p.18330

2021

Link zum Volltext

Verfügbarkeit prüfen

Phenytoin and phenobarbital inhibit human HERG potassium channels

Epilepsy research, 2003, Vol.55 (1), p.147-157

2003

Link zum Volltext

Verfügbarkeit prüfen

Scorpion Potassium Channel-blocking Defensin Highlights a Functional Link with Neurotoxin

The Journal of biological chemistry, 2016-03, Vol.291 (13), p.7097-7106

2016

Link zum Volltext

Verfügbarkeit prüfen

Facilitation of I Kr current by some hERG channel blockers suppresses early afterdepolarizations

The Journal of general physiology, 2019-02, Vol.151 (2), p.214-230

2019

Link zum Volltext

Verfügbarkeit prüfen

Interaction of the Inhibitory Peptides ShK and HmK with the Voltage-Gated Potassium Channel K V 1.3: Role of Conformational Dynamics

Journal of chemical information and modeling, 2023-05, Vol.63 (10), p.3043-3053

2023

Link zum Volltext

Verfügbarkeit prüfen

A Fluorescent Peptide Toxin for Selective Visualization of the Voltage-Gated Potassium Channel K V 1.3

Bioconjugate chemistry, 2022-11, Vol.33 (11), p.2197-2212

2022

Link zum Volltext

Verfügbarkeit prüfen

Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade

Circulation (New York, N.Y.), 2015-12, Vol.132 (23), p.2203-2211

2015

Link zum Volltext

Verfügbarkeit prüfen

Citral inhibits the nociception in the rat formalin test: effect of metformin and blockers of opioid receptor and the NO-cGMP-K + channel pathway

Canadian journal of physiology and pharmacology, 2022-04, Vol.100 (4), p.306

2022

Link zum Volltext

Verfügbarkeit prüfen

Crystal Structure of the Human K2P TRAAK, a Lipid-and Mechano-Sensitive K⁺ Ion Channel

Science (American Association for the Advancement of Science), 2012-01, Vol.335 (6067), p.436-441

2012

Link zum Volltext

Verfügbarkeit prüfen

Low intravascular pressure activates endothelial cell TRPV4 channels, local Ca²⁺ events, and IKCₐ channels, reducing arteriolar tone

Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (44), p.18174-18179

2012

Link zum Volltext

Verfügbarkeit prüfen

Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses

Nature neuroscience, 2012-03, Vol.15 (3), p.477-486

2012

Link zum Volltext

Verfügbarkeit prüfen

Toward in vivo-relevant hERG safety assessment and mitigation strategies based on relationships between non-equilibrium blocker binding, three-dimensional channel-blocker interactions, dynamic occupancy, dynamic exposure, and cellular arrhythmia

PloS one, 2020-11, Vol.15 (11), p.e0234946

2020

Link zum Volltext

Verfügbarkeit prüfen

Virtual screening of DrugBank database for hERG blockers using topological Laplacian-assisted AI models

Computers in biology and medicine, 2023-02, Vol.153, p.106491, Article 106491

2023

Link zum Volltext

Verfügbarkeit prüfen

Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment

Pharmacology & therapeutics (Oxford), 2006-07, Vol.111 (1), p.224-259

2006

Link zum Volltext

Verfügbarkeit prüfen

8-hydroxypinoresinol-4-O-β-D-glucoside from Valeriana officinalis L. Is a Novel Kv1.5 Channel Blocker

Journal of ethnopharmacology, 2021-08, Vol.276, p.114168-114168, Article 114168

2021

Link zum Volltext

Verfügbarkeit prüfen

An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel

Journal of pharmacological and toxicological methods, 2016-09, Vol.81 (C), p.251-262

2016

Link zum Volltext

Verfügbarkeit prüfen

Tuning Photochromic Ion Channel Blockers

ACS chemical neuroscience, 2011-09, Vol.2 (9), p.536-543

2011

Link zum Volltext

Verfügbarkeit prüfen

Somatostatin Is Only Partly Required for the Glucagonostatic Effect of Glucose but Is Necessary for the Glucagonostatic Effect of K ATP Channel Blockers

Diabetes (New York, N.Y.), 2018-11, Vol.67 (11), p.2239

2018

Link zum Volltext

Verfügbarkeit prüfen

The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry

Journal of antimicrobial chemotherapy, 2014-08, Vol.69 (8), p.2123-2131

2014

Link zum Volltext

Verfügbarkeit prüfen

VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium Channels

Molecular pharmacology, 2022-05, Vol.101 (5), p.357-370

2022

Link zum Volltext

Verfügbarkeit prüfen

Paxilline inhibits BK channels by an almost exclusively closed-channel block mechanism

The Journal of general physiology, 2014-11, Vol.144 (5), p.415-440

2014

Link zum Volltext

Verfügbarkeit prüfen

Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome

The New England journal of medicine, 2010-10, Vol.363 (15), p.1397-1409

2010

Link zum Volltext

Verfügbarkeit prüfen

26 – 50 von 40.492

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library - AutoHoldings Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35.156)
Mit Volltextzugriff
(35.227)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(29.738)
Life Sciences & Biomedicine
(27.523)
Animals
(22.790)
Humans
(11.638)
Male
(10.590)
Rats
(9.285)
Pharmacology & Pharmacy
(8.827)
Biological And Medical Sciences
(7.956)
Physiology
(6.831)
Neurosciences
(6.102)
Neurosciences & Neurology
(5.727)
Female
(5.622)
In Vitro Techniques
(5.057)
Medical Sciences
(4.927)
Cardiovascular System & Cardiology
(4.031)
Calcium - Metabolism
(4.014)
Potassium Channel Blockers - Pharmacology
(4.012)
Mice
(3.996)
Patch-Clamp Techniques
(3.681)
Calcium Channel Blockers - Pharmacology
(3.522)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(20.195)
IngentaConnect_期刊（NSTL购买）
(19.817)
Ovid SocietyJournals and Single Titles
(10.685)
IngentaConnect Journals
(9.501)
Elsevier ScienceDirect Journals
(6.812)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(5.955)
SpringerNature Journals
(5.551)
Single Journals
(5.196)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(3.855)
Nexis
(2.282)
Taylor & Francis
(1.914)
Ebook Central Perpetual and DDA
(1.803)
Nature_系列刊
(1.742)
Taylor & Francis Journals Complete
(1.630)
eBooks on EBSCOhost
(1.599)
Factiva
(1.406)
SAGE Publications
(1.216)
Oxford University Press Journals Current
(1.019)
Oxford Journals 2020 Medicine
(827)
JSTOR All Journals
(783)
Wiley Online Library
(0)

16 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis

Ions and blockers in potassium channels: insights from free energy simulations

3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel

K Ca channel blockers increase effectiveness of the EGF receptor TK inhibitor erlotinib in non-small cell lung cancer cells (A549)

Phenytoin and phenobarbital inhibit human HERG potassium channels

Scorpion Potassium Channel-blocking Defensin Highlights a Functional Link with Neurotoxin

Facilitation of I Kr current by some hERG channel blockers suppresses early afterdepolarizations

Interaction of the Inhibitory Peptides ShK and HmK with the Voltage-Gated Potassium Channel K V 1.3: Role of Conformational Dynamics

A Fluorescent Peptide Toxin for Selective Visualization of the Voltage-Gated Potassium Channel K V 1.3

Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade

Citral inhibits the nociception in the rat formalin test: effect of metformin and blockers of opioid receptor and the NO-cGMP-K + channel pathway

Crystal Structure of the Human K2P TRAAK, a Lipid-and Mechano-Sensitive K⁺ Ion Channel

Low intravascular pressure activates endothelial cell TRPV4 channels, local Ca²⁺ events, and IKCₐ channels, reducing arteriolar tone

Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses

Toward in vivo-relevant hERG safety assessment and mitigation strategies based on relationships between non-equilibrium blocker binding, three-dimensional channel-blocker interactions, dynamic occupancy, dynamic exposure, and cellular arrhythmia

Virtual screening of DrugBank database for hERG blockers using topological Laplacian-assisted AI models

Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment

8-hydroxypinoresinol-4-O-β-D-glucoside from Valeriana officinalis L. Is a Novel Kv1.5 Channel Blocker

An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel

Tuning Photochromic Ion Channel Blockers

Somatostatin Is Only Partly Required for the Glucagonostatic Effect of Glucose but Is Necessary for the Glucagonostatic Effect of K ATP Channel Blockers

The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry

VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium Channels

Paxilline inhibits BK channels by an almost exclusively closed-channel block mechanism

Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome

Aktive Filter

Suchergebnisse filtern